{"hands_on_practices": [{"introduction": "One of the most powerful ways to probe an enzyme's active site is to observe how it interacts with inhibitors. Distinguishing between different types of inhibition, such as competitive and non-competitive, requires careful experimental design. This practice challenges you to think like an enzymologist and devise a classic kinetic experiment to reveal an inhibitor's mechanism of action, a fundamental skill in both biochemistry and drug discovery [@problem_id:2292943].", "problem": "A research team has isolated a novel enzyme, \"synthetase-Q,\" which is essential for a metabolic pathway in a newly discovered bacterium. They have also synthesized a molecule, \"Compound-Z,\" which is observed to decrease the rate of the reaction catalyzed by synthetase-Q. To understand the mechanism of inhibition, the team needs to determine whether Compound-Z acts as a competitive or a non-competitive inhibitor.\n\nA competitive inhibitor binds to the enzyme's active site, preventing the substrate from binding. A non-competitive inhibitor binds to a different site on the enzyme (an allosteric site), altering the enzyme's shape and reducing its catalytic efficiency, but does not prevent the substrate from binding.\n\nWhich of the following experimental procedures is the most direct and conclusive method for distinguishing between these two types of inhibition?\n\nA. Measure the reaction rate in a series of experiments where the concentrations of both the enzyme and its substrate are held constant, while the concentration of Compound-Z is progressively increased.\n\nB. Using analytical chemistry techniques, determine the three-dimensional structures of the enzyme alone, the enzyme-substrate complex, and the enzyme-inhibitor complex to see where Compound-Z binds.\n\nC. Measure the reaction rate at a single, fixed, non-saturating concentration of the substrate, first in the absence and then in the presence of a fixed concentration of Compound-Z.\n\nD. Measure the reaction rate across a wide range of substrate concentrations, performing one set of measurements in the absence of Compound-Z and another set in the presence of a fixed concentration of Compound-Z.\n\nE. Measure the reaction rate with a fixed concentration of substrate and Compound-Z at several different pH values to see how the inhibition is affected by protonation states.", "solution": "Begin with the Michaelis–Menten rate law for an uninhibited, single-substrate enzyme:\n$$\nv=\\frac{V_{\\max}[S]}{K_{m}+[S]},\n$$\nwhere $V_{\\max}=k_{\\text{cat}}[E]_{\\text{tot}}$ and $K_{m}$ is the Michaelis constant.\n\nFor competitive inhibition, the inhibitor $I$ binds to the free enzyme at the active site, competing with $S$. Under standard steady-state or rapid-equilibrium assumptions with inhibition constant $K_{i}=\\frac{[E][I]}{[EI]}$, the fraction of enzyme available to bind $S$ is reduced by a factor $\\alpha$, where\n$$\n\\alpha=1+\\frac{[I]}{K_{i}}.\n$$\nAlgebraically, one finds\n$$\nv=\\frac{V_{\\max}[S]}{\\alpha K_{m}+[S]}.\n$$\nThus, in competitive inhibition, $V_{\\max}$ is unchanged and the apparent $K_{m}$ increases to $\\alpha K_{m}$. Equivalently, at very high $[S]$, the inhibitor effect is overcome and $v\\to V_{\\max}$.\n\nFor pure non-competitive inhibition, the inhibitor binds to an allosteric site on both $E$ and $ES$ with equal affinity and reduces catalytic capacity without altering $S$ binding. Let $K_{i}^{\\prime}$ denote the inhibition constant for binding to $ES$ (equal to $K_{i}$ in the pure case). The effect is to scale $V_{\\max}$ by a factor $\\alpha^{\\prime}$ with\n$$\n\\alpha^{\\prime}=1+\\frac{[I]}{K_{i}^{\\prime}},\n$$\ngiving\n$$\nv=\\frac{\\left(\\frac{V_{\\max}}{\\alpha^{\\prime}}\\right)[S]}{K_{m}+[S]}.\n$$\nThus, for pure non-competitive inhibition, the apparent $V_{\\max}$ decreases to $V_{\\max}/\\alpha^{\\prime}$ while $K_{m}$ remains unchanged. At very high $[S]$, the inhibited rate still plateaus below $V_{\\max}$ and cannot be overcome by increasing $[S]$.\n\nThese distinct, diagnostic signatures are revealed by measuring $v$ across a wide range of $[S]$ with and without a fixed $[I]$. Specifically:\n- Competitive: same $V_{\\max}$, increased apparent $K_{m}$ (rightward shift); Lineweaver–Burk plots intersect on the $y$-axis (same $1/V_{\\max}$).\n- Non-competitive (pure): decreased $V_{\\max}$, unchanged $K_{m}$; Lineweaver–Burk plots intersect on the $x$-axis (same $-1/K_{m}$).\n\nTherefore, the most direct and conclusive method is to measure initial rates over a broad substrate concentration range in the absence and presence of a fixed inhibitor concentration, then extract $V_{\\max}$ and $K_{m}$ (or their apparent values) to determine the inhibition type.\n\nWhy other options are insufficient:\n- A varies $[I]$ at a single $[S]$ and fixed $[E]$, which cannot distinguish changes in $K_{m}$ versus $V_{\\max}$.\n- B determines structures; while informative about binding sites, structure alone may not conclusively establish functional inhibition type under catalytic conditions and is not the standard kinetic criterion.\n- C measures at a single, non-saturating $[S]$, which cannot separate effects on $K_{m}$ and $V_{\\max}$.\n- E explores pH effects, which are indirect and non-diagnostic for distinguishing competitive versus non-competitive mechanisms.\n\nThus, choice D is the correct, classical kinetic experiment to distinguish competitive from non-competitive inhibition.", "answer": "$$\\boxed{D}$$", "id": "2292943"}, {"introduction": "The 'induced-fit' model captures the dynamic nature of enzyme-substrate interaction, where the enzyme changes shape upon binding. This practice provides a hands-on opportunity to analyze biophysical data from a Förster Resonance Energy Transfer (FRET) experiment [@problem_id:2292980]. You will use the distance-dependent FRET efficiency equation to calculate the actual distance between probes on the enzyme and an inhibitor, thereby quantifying the magnitude of a conformational change and gathering direct evidence for induced fit.", "problem": "An enzymologist is investigating the binding mechanism of a novel enzyme, Tryptophan Synthase Mimic (TSM), using a biophysical technique called Förster Resonance Energy Transfer (FRET). FRET is a mechanism describing energy transfer between two light-sensitive molecules (fluorophores). The efficiency of this energy transfer, $E$, is highly dependent on the distance, $r$, between the donor and acceptor fluorophores, as described by the equation:\n$$E = \\frac{1}{1 + (r/R_0)^{6}}$$\nwhere $R_0$ is the Förster radius, a characteristic distance at which the transfer efficiency is 50%. For this experiment, the Förster radius for the chosen donor-acceptor pair is $R_0 = 5.6 \\text{ nm}$.\n\nThe experimental setup is as follows: A donor fluorophore is attached to a flexible loop on the surface of TSM, which is known to be situated near the enzyme's active site. A non-reactive competitive inhibitor, designed to mimic the enzyme's natural substrate, is synthesized with an acceptor fluorophore attached to it. It is assumed that the position of the acceptor fluorophore is fixed relative to the geometric center of the inhibitor.\n\nTwo competing models for enzyme-inhibitor interaction are considered:\n1.  **Rigid-Scaffold Model**: In this model, the enzyme's active site is a rigid, pre-formed cavity. The inhibitor simply docks into this static structure. Based on computer modeling of this rigid docking, the expected distance between the donor fluorophore on the loop and the acceptor fluorophore on the bound inhibitor would be $r_{rigid} = 7.1 \\text{ nm}$.\n2.  **Induced-Fit Model**: In this model, the initial binding of the inhibitor is followed by a conformational change in the enzyme. This change alters the shape of the active site and its surroundings to achieve a tighter, more complementary fit, which would involve movement of the flexible loop.\n\nIn the actual laboratory experiment, the enzymologist saturates a solution of the donor-labeled TSM enzyme with the acceptor-labeled inhibitor and measures a steady-state FRET efficiency of $E_{exp} = 0.85$.\n\nCalculate the magnitude of the conformational change, specifically, the distance by which the flexible loop moves closer to the bound inhibitor in the actual experiment compared to the hypothetical position predicted by the Rigid-Scaffold Model. Express your answer in nanometers (nm), rounded to two significant figures.", "solution": "The FRET efficiency-distance relation is given by\n$$E=\\frac{1}{1+\\left(\\frac{r}{R_{0}}\\right)^{6}}.$$\nTo solve for $r$ in terms of $E$ and $R_{0}$, invert the equation:\n$$\\frac{1}{E}=1+\\left(\\frac{r}{R_{0}}\\right)^{6} \\quad \\Rightarrow \\quad \\left(\\frac{r}{R_{0}}\\right)^{6}=\\frac{1}{E}-1.$$\nThus,\n$$r=R_{0}\\left(\\frac{1}{E}-1\\right)^{\\frac{1}{6}}.$$\nWith $E_{exp}=0.85$ and $R_{0}=5.6 \\text{ nm}$,\n$$\\frac{1}{E_{exp}}-1=\\frac{1-0.85}{0.85}=\\frac{0.15}{0.85}=\\frac{15}{85}=\\frac{3}{17},$$\nso the experimental donor-acceptor distance is\n$$r_{exp}=5.6\\left(\\frac{3}{17}\\right)^{\\frac{1}{6}} \\text{ nm} \\approx 4.20 \\text{ nm}.$$\nThe Rigid-Scaffold Model predicts $r_{rigid}=7.1 \\text{ nm}$. The magnitude of loop movement toward the inhibitor is the decrease in distance:\n$$\\Delta r=r_{rigid}-r_{exp}=7.1-4.20=2.90 \\text{ nm}.$$\nRounding to two significant figures gives $2.9 \\text{ nm}$.", "answer": "$$\\boxed{2.9}$$", "id": "2292980"}, {"introduction": "Many enzymes utilize metal ion cofactors to perform difficult chemistry, and the reactivity of these cofactors is exquisitely tuned by their coordinating amino acid ligands. This advanced problem challenges you to predict how mutating a coordinating residue alters the chemical properties of a catalytic zinc ion's active site [@problem_id:2292963]. Solving this requires synthesizing your knowledge of amino acid properties, metal coordination, and the principles of acid-base catalysis to understand how an active site's chemical environment is engineered for function.", "problem": "A biochemist is studying a hypothetical metalloenzyme, \"Aquahydrolase,\" which utilizes a zinc ion cofactor in its active site to catalyze the hydrolysis of a substrate. In the wild-type enzyme, the catalytic Zn(II) ion is held in a tetrahedral coordination geometry by the side chains of two histidine residues, one cysteine residue, and a water molecule. This zinc-bound water molecule serves as the nucleophile in the reaction mechanism, requiring deprotonation to the more potent hydroxide ion ($\\text{OH}^-$) to initiate the attack.\n\nTo investigate the role of the coordinating cysteine, the biochemist performs site-directed mutagenesis to create a C123H mutant, where the cysteine at position 123 is replaced by a histidine. In this mutant enzyme, the Zn(II) ion is now coordinated by three histidine residues and a water molecule.\n\nAssuming no significant changes in the overall protein fold or active site geometry, which of the following statements most accurately describes the expected effect of the C123H mutation on the properties of the zinc-bound water molecule?\n\nA. The pKa of the bound water will decrease because replacing the anionic cysteine thiolate with a neutral histidine increases the Lewis acidity of the Zn(II) ion, leading to stronger polarization of the water molecule.\n\nB. The pKa of the bound water will increase because the histidine side chain is physically larger than the cysteine side chain, creating steric hindrance that destabilizes the resulting hydroxide ion.\n\nC. The pKa of the bound water will increase because replacing the cysteine thiolate with a neutral histidine decreases the Lewis acidity of the Zn(II) ion, making it less capable of stabilizing the hydroxide product of deprotonation.\n\nD. The pKa of the bound water will decrease because histidine is a \"harder\" ligand than cysteine, and a harder coordination environment for the borderline Zn(II) acid inherently increases the acidity of all bound ligands.\n\nE. The pKa will remain unchanged because both histidine and cysteine are effective metal-coordinating residues, and the formal +2 charge on the zinc ion is the sole determinant of its Lewis acidity.", "solution": "We analyze the acid-base equilibrium of the zinc-bound water in the active site. The relevant deprotonation is\n$$\n[\\mathrm{Zn}(\\mathrm{L})_{3}(\\text{H}_2\\text{O})]^{n+} \\rightleftharpoons [\\mathrm{Zn}(\\mathrm{L})_{3}(\\text{OH}^{-})]^{(n-1)+} + \\text{H}^{+},\n$$\nwith equilibrium constant\n$$\nK_{a}=\\frac{[\\text{H}^{+}]\\,[\\mathrm{Zn}-\\text{OH}^{-}]}{[\\mathrm{Zn}-\\text{H}_2\\text{O}]}, \\quad pK_{a}=-\\log_{10}K_{a}.\n$$\nA more Lewis acidic metal center stabilizes the conjugate base $[\\text{Zn}-\\text{OH}^{-}]$ and polarizes the O–H bonds more strongly, which increases $K_{a}$ and therefore decreases $pK_{a}$. Thus, any modification that increases the effective Lewis acidity of $\\mathrm{Zn(II)}$ will decrease the $pK_{a}$ of the bound water.\n\nNext, we relate ligand identity to metal Lewis acidity. In the wild type, Zn(II) is coordinated by two neutral histidines (imidazole donors), one anionic cysteine thiolate, and one water. The inner-sphere formal charge is\n$q_{\\text{WT}}=+2+0+0-1=+1.$\nIn the mutant (C123H), Zn(II) is coordinated by three neutral histidines and one water, giving\n$q_{\\text{mut}}=+2+0+0+0=+2.$\nReplacing an anionic thiolate (strong anionic sigma donor) with a neutral imidazole reduces electron donation to the metal and increases the complex’s formal positive character. Both effects increase the effective Lewis acidity of Zn(II), thereby stabilizing the deprotonated $[\\text{Zn}-\\text{OH}^{-}]$ and lowering the $pK_{a}$ of the bound water.\n\nTherefore, the expected effect of the C123H mutation is a decrease in the $pK_{a}$ of the zinc-bound water due to increased Lewis acidity and stronger polarization of the coordinated water. This corresponds to statement A.\n\nBriefly excluding alternatives:\n- B invokes steric hindrance as the cause; sterics are not the primary determinant of the $pK_{a}$ here.\n- C reverses the Lewis acidity trend; replacing an anionic thiolate with a neutral histidine increases, not decreases, Lewis acidity.\n- D appeals to hardness qualitatively; while Zn(II) is borderline and histidine is harder than cysteine, the dominant effect on $pK_{a}$ arises from ligand charge and donor strength, captured correctly by A.\n- E is incorrect because ligand identity and charge distribution modulate metal Lewis acidity beyond the formal +2 oxidation state.\n\nHence, A is the most accurate statement.", "answer": "$$\\boxed{A}$$", "id": "2292963"}]}